These findings align with the research conducted by Akhani et al. [44] and Ahmed et al. [45], suggesting that the diabetogenic effect of STZ leads to damage and reduction in the number of pancreatic β-cells in the Langerhans islets, resulting in impaired β-cell function and reduced insulin production, ultimately leading to hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.